CN108926651A - 一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂 - Google Patents
一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂 Download PDFInfo
- Publication number
- CN108926651A CN108926651A CN201811083504.9A CN201811083504A CN108926651A CN 108926651 A CN108926651 A CN 108926651A CN 201811083504 A CN201811083504 A CN 201811083504A CN 108926651 A CN108926651 A CN 108926651A
- Authority
- CN
- China
- Prior art keywords
- boils
- pruitus
- impurity
- abscess
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 74
- 239000002674 ointment Substances 0.000 title claims abstract description 34
- 206010007247 Carbuncle Diseases 0.000 title claims abstract description 25
- 206010000269 abscess Diseases 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 39
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 18
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 16
- 240000004980 Rheum officinale Species 0.000 claims abstract description 16
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 16
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 15
- 241000282898 Sus scrofa Species 0.000 claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 12
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 12
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims abstract description 11
- 241000951473 Schizonepeta Species 0.000 claims abstract description 11
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 11
- 239000009136 dragon's blood Substances 0.000 claims abstract description 11
- 235000005206 Hibiscus Nutrition 0.000 claims abstract description 8
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims abstract description 8
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims abstract description 8
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 7
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 7
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 229940041616 menthol Drugs 0.000 claims abstract description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940099259 vaseline Drugs 0.000 claims abstract description 5
- 244000247747 Coptis groenlandica Species 0.000 claims abstract 5
- 208000025865 Ulcer Diseases 0.000 claims description 53
- 231100000397 ulcer Toxicity 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 239000012535 impurity Substances 0.000 claims description 24
- 208000010445 Chilblains Diseases 0.000 claims description 19
- 206010008528 Chillblains Diseases 0.000 claims description 19
- 201000004624 Dermatitis Diseases 0.000 claims description 19
- 206010021531 Impetigo Diseases 0.000 claims description 19
- 206010053615 Thermal burn Diseases 0.000 claims description 19
- 208000010668 atopic eczema Diseases 0.000 claims description 19
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 18
- 208000004396 mastitis Diseases 0.000 claims description 17
- 241000196324 Embryophyta Species 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 241000238631 Hexapoda Species 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 11
- 239000002689 soil Substances 0.000 claims description 9
- 240000007817 Olea europaea Species 0.000 claims description 8
- 241000207923 Lamiaceae Species 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 244000061520 Angelica archangelica Species 0.000 claims description 4
- 241000205571 Caulophyllum Species 0.000 claims description 4
- 241001415288 Coccidae Species 0.000 claims description 4
- 241000219071 Malvaceae Species 0.000 claims description 4
- 244000021150 Orbignya martiana Species 0.000 claims description 4
- 235000014643 Orbignya martiana Nutrition 0.000 claims description 4
- 241000205407 Polygonum Species 0.000 claims description 4
- 235000008090 Rheum palmatum Nutrition 0.000 claims description 4
- 240000001745 Rheum palmatum Species 0.000 claims description 4
- 239000006227 byproduct Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 229910052949 galena Inorganic materials 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical compound [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 230000003647 oxidation Effects 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 229910052709 silver Inorganic materials 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 3
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 3
- 235000018062 Boswellia Nutrition 0.000 claims description 3
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 3
- 241000037738 Coptis omeiensis Species 0.000 claims description 3
- 244000082204 Phyllostachys viridis Species 0.000 claims description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 3
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 3
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 3
- 239000011425 bamboo Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 229910000464 lead oxide Inorganic materials 0.000 claims description 3
- 239000004571 lime Substances 0.000 claims description 3
- 229910052573 porcelain Inorganic materials 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 239000009286 sanguis draxonis Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 230000008093 supporting effect Effects 0.000 claims description 3
- 240000007551 Boswellia serrata Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 208000003251 Pruritus Diseases 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000008961 swelling Effects 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 238000001784 detoxification Methods 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 abstract description 2
- 229950010883 phencyclidine Drugs 0.000 abstract description 2
- 210000001699 lower leg Anatomy 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 17
- 230000035876 healing Effects 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- 241000218202 Coptis Species 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 230000000007 visual effect Effects 0.000 description 8
- 239000001993 wax Substances 0.000 description 8
- 208000033809 Suppuration Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 206010063409 Acarodermatitis Diseases 0.000 description 5
- 241000447727 Scabies Species 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 238000002651 drug therapy Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000005687 scabies Diseases 0.000 description 5
- 230000036269 ulceration Effects 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 210000001217 buttock Anatomy 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000001364 upper extremity Anatomy 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000002636 symptomatic treatment Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241001608538 Boswellia Species 0.000 description 2
- 244000056139 Brassica cretica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 235000001667 Vitex agnus castus Nutrition 0.000 description 2
- 244000063464 Vitex agnus-castus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000001716 anti-fugal effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229960002129 cefixime Drugs 0.000 description 2
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000005202 decontamination Methods 0.000 description 2
- 230000003588 decontaminative effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 229940127249 oral antibiotic Drugs 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010053555 Arthritis bacterial Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- -1 Compound Dexamethasone Acetate Chemical class 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010016059 Facial pain Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013196 antibiotherapy Methods 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 208000025255 bacterial arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- XMFOQHDPRMAJNU-UHFFFAOYSA-N lead(ii,iv) oxide Chemical compound O1[Pb]O[Pb]11O[Pb]O1 XMFOQHDPRMAJNU-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Developmental Biology & Embryology (AREA)
- Neurosurgery (AREA)
Abstract
本发明涉及一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂及制备方法，属于中药制药领域，本发明药物包括：密陀僧、雄黄、当归、木鳖子、大黄、黄芩、黄连、血竭、芙蓉叶、乳香、没药、苦参、薄荷脑、荆芥、虫白腊、黄丹、凡士林、单硬脂酸甘油酯、野猪脂，本发明提供一种制作简单、效果好、不易复发、治愈率高的一种膏剂，它具有活血消肿、滋阴凉血、消炎止痒、清热解毒、祛腐生肌、拔毒散结、久不收口，总有效率95％，治愈率90％。
Description
技术领域
本发明涉及一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂及制备方法，属于中药制药领域。
背景技术
痈疖疔疮是指痈疽、疖肿、疗疮之类的多种体表感染性疾病。其主要症状为患处红、肿、热、痛等不适症状，此类疾病可以包括全身各部位的毛囊炎、蜂窝组织炎、急性淋巴结炎、淋巴管炎、腮腺炎、带状疱疹、化脓性关节炎、多发性深部脓肿等感染性疾病。
中医认为：痈疖疔疮是外感火热之毒致病，或过食膏粱厚味，脏腑蕴毒，或因皮肤外伤，毒邪乘隙侵入，以致气血凝滞而引起本病。《鬼遗方》云：凡痈疽外热内疼者，是有客邪，内有积毒，欲作脓透之候。
西医目前大多采用抗生素疗法来治疗此类疾病，大多治标不治本，因此急需寻找一种可有效治疗痈疖疔疮之类的疾病药物，要解决的问题。
发明内容
针对现有治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒存在的不足，本发明提供一种制作简单、效果好、不易复发、治愈率高的一种膏剂。本发明具有活血消肿、滋阴凉血、消炎止痒、清热解毒、祛腐生肌、拔毒散结、久不收口，总有效率94％，治愈率90％。
解决上述问题而采用的技术方案：(用量为重量份)
优选方案一：各组分的用量范围：
优选方案二：各组分的用量：(用量为重量份)
所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于：它有下列步骤制成：
第一步选用药物、炮制药物：它有下列步骤制成：
(1)密陀僧：为粗制氧化铅，以往取自方铅矿提炼银、铅时沉积于炉底的副产品，目前系将铅熔融后，用长棍取出浸入冷水中，熔铅冷却后变成氧化铅固体，即为密陀僧；
(2)雄黄：为硫化物类矿物雄黄的矿石，雄黄在矿中质软如泥，见空气即变坚硬，一般用竹刀剔取其熟透部分，除去杂质泥土；
(3)当归：为伞形科植物当归的根，拣去杂质，洗净，切片晒干；
(4)木鳖子：为葫芦科植物木鳖子的成熟种子，除去杂质，洗净，晒干，用时连壳打碎，或去壳取仁；
(5)大黄：为蓼科植物掌叶大黄、唐古特大黄或药用大黄的根茎，9-10月间选择生长三年以上的植株，挖取根茎，切除茎叶、支根，刮去粗皮及顶牙，风干、烘干或切片晒干；
(6)黄芩：为唇形科植物黄芩的根，拣去杂质，除去残茎，用凉水浸润或置开水中稍浸捞出，润透后切片晒干；
(7)黄连：为毛莨科植物黄连、三角叶黄连、峨嵋野连或云南黄连的根茎，拣去杂质，洗净泥土，润透，切片，阴干；
(8)血竭：为棕榈科植物麒麟竭果实及树干中的树脂，拭去灰尘，敲成小块，于冬季干燥天气，放在石灰坛内使燥，然后乘脆研末；
(9)芙蓉叶：为锦葵科植物木芙蓉的叶，夏秋季采摘叶，阴干或晒干，取原药材，除去杂质，喷淋清水，稍润，切丝，干燥；
(10)乳香：为橄榄科植物卡氏乳香树的胶树脂，捡去砂子杂质；
(11)没药：为橄榄科植物没药或爱伦堡没药的胶树脂；
(12)苦参：为豆科植物苦参的根，捡尽杂质，除去残径，洗净泥土，用水浸泡，捞出，润透，切片，晒干；
(13)荆芥：为唇形科植物荆芥的全草，捡尽杂质，用水略泡，捞出切断，晒干；
(14)虫白蜡：为介壳虫科昆虫白蜡虫的雄虫，8-9月间采腊，清晨用刀将包有腊质的树枝切下，放入沸水锅中煮之，使腊质熔化而浮于水面，冷后凝结成块，取出，再加水加热熔化，过滤后凝固即成；
(15)野猪脂：为猪科动物野猪的脂肪；
(15)野猪脂：为猪科动物野猪的脂肪；
第二步：先将血竭、薄荷脑研碎，备用；首先熬制野猪脂，微火加热熔化，继续加热至摄氏85-90度时，依次下密陀僧、雄黄、当归、木鳖子、大黄、黄芩、黄连、芙蓉叶、苦参、荆芥、乳香、没药，煎炸以上诸药，用油煎至黑枯色；次下虫白蜡、凡士林，继续煎炸5分钟后，将药渣滤净，最后下黄丹、单硬脂酸甘油酯，用柳枝搅拌，变为黑色，然后将血竭、薄荷脑粉掺入膏中，拌匀，软硬适宜，瓷盒内贮藏。
所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于：治疗带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮等。
药理作用：
密陀僧，为粗制氧化铅，以往取自方铅矿提炼银、铅时沉积于炉底的副产品，目前系将铅熔化后，用长棍在熔铅中旋转几次，部分熔铅粘附于铁棍上，然后取出浸入冷水中，熔铅冷却后变成氧化铅固体，即为密陀僧。
雄黄，为硫化矿类矿物雄黄的矿石，有抗菌作用，味辛苦，温，有毒，入心肝胃经，具有燥湿，祛风，杀虫，解毒之功效，治疗疥癣，秃顶，痈疽，走马牙疳，缠腰蛇丹，破伤风，蛇虫蛰伤，腋臭，臁疮，哮喘，喉痹，痔漏等；
当归，为伞形科植物当归的根，味甘辛，性温，入心肝脾经，具有补血和血，调经止痛，润燥滑肠，治月经不调，经闭腹痛，症瘕结聚，崩漏，血虚头痛，眩晕，痿痹，肠燥便难，赤痢后重，痈疽疮疡，跌扑损伤等；
木鳖子，为葫芦科植物木鳖子的成熟种子，木鳖子，Monordica cochinensi(Lour.)Spr.，味苦微甘，入肝脾胃经，具有消肿散结，祛毒，治痈肿，牙疮，痔疮，无名肿毒，癣疮，风湿痹痛，筋脉拘挛等；
大黄，为蓼科植物掌叶大黄、唐古特大黄或药用大黄的根劲，味苦寒，入胃、大肠、足阳明经，具有泻热毒，破积滞，行瘀血，治实热便秘，发狂，食积痞满，痢疾初起，里急后重，瘀停经闭，症瘕积聚，时行热疫，暴发赤痛，吐血，阳黄，水肿，淋浊，痈疽肿毒，疔疮，烫火伤等；
黄芩，味苦寒，入心肺胆大肠经，具有泄实火，除湿热，止血，安胎之功效，治壮热烦渴，肺热咳嗽，湿热泻痢，黄疸，热淋，吐、崩、漏，目赤肿毒，痈肿疔疮；
黄连，为毛莨科植物黄连、三角叶黄连、峨眉野连或云南黄连的根茎，黄连，Coptischinensis Franch.味苦寒，入心、肝、胃、大肠经，具有泻火，燥湿，解毒，杀虫，治时行热毒，伤寒，热盛心烦，痞满呕吐，菌痢，肺结核，咽喉肿痛，口疮，痈疽疮毒，湿疹，汤火烫伤等；
血竭，为棕榈科植物麒麟果实及树干中的树脂，具有抗真菌作用，味甘咸，具有散瘀定痛，止血生肌之功效，治跌打折伤，内伤淤痛，外伤出血不止，瘰疬，臁疮溃疡不合等；
芙蓉叶，为锦葵科植物，木芙蓉Hibiscus matabilis L.的叶，性凉，味微辛，入肺肝经，具有清热解毒、凉血止血、消肿止痛之功效，外用治疗痈疖脓肿，烧伤烫伤等，药理实验表明叶子具有明显抗真菌作用；
乳香，为橄榄科植物卡氏如橡树的胶树脂，味辛苦，性温，入脾心肝经，具有调气活血，定痛，追毒之功效，治气血凝滞，心腹疼痛，痈疖肿毒，跌打损伤，痛经，产后淤血刺痛等；
没药，橄榄科植物没药树或爱伦堡没药树的胶树脂，味苦性平，入肝经，具有散血祛瘀，消肿定痛之功效，治疗跌损、金疮、筋骨、心腹诸痛、痈疽肿痛、痔漏等；
苦参，为豆科植物苦参的根，味苦，性寒，入肝肾大肠小肠经，具有清热，燥湿，杀虫之功效，治热毒血痢，皮肤瘙痒，疥癣恶疮，阴疮湿痒，瘰疬，烫伤等；
荆芥，荆芥Schizonepeta tenuifolia(Benth)Brip.味辛性温，入肺肝经，具有发表，祛风，理血，治疗感冒发热，头痛，咽喉肿痛，中风口噤，痈肿，疥疮，瘰疬等；
虫白蜡，为介壳虫科白蜡虫的雄虫，味甘性温，具有止血，生肌，定痛，治金疮出血，尿血，下血，溃疡久溃不敛，下疳等；
黄丹，又名叫铅丹，本品为纯铅加工而成的四氧化三铅，本品的功效：治疗痈疽疮疡，能拔毒防腐，生肌敛疮，为治疗疮疡的常用药物，用治多种疮疡病症；本品还具有治疗湿疹癣疮，有攻毒杀虫，收湿止痒之功，可治疗皮肤湿痒之证；
凡士林，一种矿物蜡，它不会被皮肤吸收，能在肌肤表面形成一道保护膜，使皮肤的水分不易蒸发散失，适合皮肤干燥肌肤使用；
单硬脂酸甘油酯，为化妆品及医药膏剂中用作乳化剂，使膏体细腻，润滑；
野猪脂，为猪科动物野猪的脂肪，《日华子本草》“悦色，并除风肿毒疮、疥癣”。
本发明与现有技术相比，具有以下有益效果：
1、本发明外用药膏，直达病灶，可加强疗效；
2、本发明制作简单、效果好、不易复发、治愈率高；
3、本发明疗效好，使用安全，无毒副作用；
4、本发明药物来源于大自然，易获得，成本低，能够降低生产成本。
用法及用量：
本发明药膏的使用方法：用温水清洗皮肤后直接涂抹药膏，药物表面无需覆盖任何附着物，一天2次换药，带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹，7天为1个疗程，带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹，一般治愈需1-4个疗程；乳痈、臁疮，1个月为1疗程，一般需2-4个疗程治愈。
本发明药物禁忌：1、忌食油腻辛辣食物；2、孕妇禁止使用；3、治疗期间，忌饮酒；
具体实施方式
下面结合具体实施例对本发明做进一步补充说明：
实施例1
一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于由以下重量份配比的原料制成：(用量为重量份)
所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于：它有下列步骤制成：
第一步选用药物、炮制药物：它有下列步骤制成：
(1)密陀僧：为粗制氧化铅，以往取自方铅矿提炼银、铅时沉积于炉底的副产即为密陀僧；
(2)雄黄：为硫化物类矿物雄黄的矿石，雄黄在矿中质软如泥，见空气即变坚硬，一般用竹刀剔取其熟透部分，除去杂质泥土；
(3)当归：为伞形科植物当归的根，拣去杂质，洗净，切片晒干；
(4)木鳖子：为葫芦科植物木鳖子的成熟种子，除去杂质，洗净，晒干，用时连壳打碎，或去壳取仁；
(5)大黄：为蓼科植物掌叶大黄、唐古特大黄或药用大黄的根茎，9-10月间选择生长三年以上的植株，挖取根茎，切除茎叶、支根，刮去粗皮及顶牙，风干、烘干或切片晒干；
(6)黄芩：为唇形科植物黄芩的根，拣去杂质，除去残茎，用凉水浸润或置开水中稍浸捞出，润透后切片晒干；
(7)黄连：为毛莨科植物黄连、三角叶黄连、峨嵋野连或云南黄连的根茎，拣去杂质，洗净泥土，润透，切片，阴干；
(8)血竭：为棕榈科植物麒麟竭果实及树干中的树脂，拭去灰尘，敲成小块，于冬季干燥天气，放在石灰坛内使燥，然后乘脆研末；
(9)芙蓉叶：为锦葵科植物木芙蓉的叶，夏秋季采摘叶，阴干或晒干，取原药材，除去杂质，喷淋清水，稍润，切丝，干燥；
(10)乳香：为橄榄科植物卡氏乳香树的胶树脂，捡去砂子杂质；
(11)没药：为橄榄科植物没药或爱伦堡没药的胶树脂；
(12)苦参：为豆科植物苦参的根，捡尽杂质，除去残径，洗净泥土，用水浸泡，捞出，润透，切片，晒干；
(13)荆芥：为唇形科植物荆芥的全草，捡尽杂质，用水略泡，捞出切断，晒干；捞出，润透，切片，晒干；
(13)荆芥：为唇形科植物荆芥的全草，捡尽杂质，用水略泡，捞出切断，晒干；
(14)虫白蜡：为介壳虫科昆虫白蜡虫的雄虫，8-9月间采腊，清晨用刀将包有腊质的树枝切下，放入沸水锅中煮之，使腊质熔化而浮于水面，冷后凝结成块，取出，再加水加热熔化，过滤后凝固即成；
(15)野猪脂：为猪科动物野猪的脂肪；
第二步：先将血竭、薄荷脑研碎，备用；首先熬制野猪脂，微火加热熔化，继续加热至摄氏85-90度时，依次下密陀僧、雄黄、当归、木鳖子、大黄、黄芩、黄连、芙蓉叶、苦参、荆芥、乳香、没药，煎炸以上诸药，用油煎至黑枯色；次下虫白蜡、凡士林，继续煎炸5分钟后，将药渣滤净，最后下黄丹、单硬脂酸甘油酯，用柳枝搅拌，变为黑色，然后将血竭、薄荷脑粉掺入膏中，拌匀，软硬适宜，瓷盒内贮藏。
所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于：治疗带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮等。
用法及用量：
本发明药膏的使用方法：用双氧水清洗创面后直接涂抹药膏，药物表面无需覆盖任何附着物，一天2次换药，坚持每天换药膏，带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹，7天为1个疗程，带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹，一般治愈需1-4个疗程；乳痈、臁疮，1个月为1疗程，一般需2-4个疗程治愈。
本发明药物禁忌：1、忌食油腻辛辣食物；2、孕妇禁止使用；3、治疗期间，忌饮酒；
实施例2
一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于由以下重量份配比的原料制成：(用量为重量份)
本实施例2的制法及用法、用量及禁忌同实施例1相同。
实施例3
一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于由以下重量份配比的原料制成：(用量为重量份)
本实施例3的制法及用法、用量禁忌同实施例1相同。
实施例4
一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于由以下重量份配比的原料制成：(用量为重量份)
本实施例4的制法及用法、用量及禁忌同实施例1相同。
临床资料与治疗方法：
共收集300例本发明药物治疗带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮患者，其中带状疱疹患者26例；黄水疮患者44例；冻疮患者18例；褥疮患者26例；烧烫伤患者42例；皮肤瘙痒患者56例；湿疹患者28例；乳痈患者40例；臁疮患者20例；男性患者占127例，女性患者占173例，年龄最大者75岁，年龄最小者1岁，患病时间为1个月至2年，分为治疗组和对照组：治疗组使用本发明药物治疗，用温水清洗皮肤后直接涂抹药膏，药物表面无需覆盖任何附着物，一天2次换药，坚持每天换药膏；
对照组：带状疱疹采用抗病毒药物治疗，阿昔洛韦片，一日三次，一次0.8g，口服，无特殊治疗方法，且病程长，加重患者痛苦，易留后遗症如神经痛；
黄水疮：西医采用如：双氧水冲洗后再用生理盐水清洗干净，口服抗菌药物治疗，如阿奇霉素片，每次0.1g，一日两次。
冻疮：采用物理保温办法，注意保暖。
褥疮、臁疮：西药无特效治疗，只有常规清洗溃疡面，如：双氧水、生理盐水配合清洗；或双氧水、甲硝锉注射液配合清洗。
烧烫伤：西医采用对症治疗，如：红霉素软膏涂抹，头孢克肟胶囊，一次0.1克，一日三次口服。
皮肤瘙痒：西药对症治疗如皮炎平，涂抹，口服氯雷他定，一次10mg，一日一次。
湿疹：目前西医对湿疹尚无特殊方法，多采用内服抗组胺药物、激素类药物治疗，临时抑制，如：口服西药、口服激素，外用软膏、乳剂等，只能缓解症状，不能从根本上解决问题。
乳痈：口服抗生素对症治疗：如，头孢克肟胶囊，一日两次，一次0.1克口服。
随机将300个病例分为治疗组和对照组，具有可比性。
纳入病例标准：
西医诊断为带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮的患者。
疗效判断标准：
1、治愈：主要症状基本消失；
2、有效：主要症状明显改善；
3、无效：主要症状无明显改善或加重。
治疗结果：治疗组：
带状疱疹的患者13例：治愈者13例，显效者0例，有效者0例，无效者0例；
黄水疮的患者22例：治愈者22例，显效者0例，有效者0例，无效者0例；
冻疮的患者9例：治愈者9例，显效者0例，有效者0例，无效者0例；
褥疮的患者13例：治愈者9例，显效者1例，有效者1例，无效者2例；
烧烫伤的患者21例：治愈者18例，显效者1例，有效者1例，无效者1例；
皮肤瘙痒的患者28例：治愈者27例，显效者0例，有效者0例，无效者1例；
湿疹的患者14例：治愈者13例，显效者0例，有效者0例，无效者1例；
乳痈的患者20例：治愈者17例，显效者2例，有效者0例，无效者1例；
臁疮的患者10例：治愈者7例，显效者0例，有效者0例，无效者3例。
治疗组：150例带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮患者治疗效果附表如下：
| 病例数 | 治愈数 | 显效数 | 有效数 | 无效数 | 有效率 | |
| 带状疱疹 | 13 | 13 | 0 | 0 | 0 | 100％ |
| 黄水疮 | 22 | 22 | 0 | 0 | 0 | 100％ |
| 冻疮 | 9 | 9 | 0 | 0 | 0 | 100％ |
| 褥疮 | 13 | 9 | 1 | 1 | 2 | 84.62％ |
| 烧烫伤 | 21 | 18 | 1 | 1 | 1 | 95.24％ |
| 皮肤瘙痒 | 28 | 27 | 0 | 0 | 1 | 96.43％ |
| 湿疹 | 14 | 13 | 0 | 0 | 1 | 92.86％ |
| 乳痈 | 20 | 17 | 2 | 0 | 1 | 85％ |
| 臁疮 | 10 | 7 | 0 | 0 | 3 | 70％ |
治疗组：总有效率：94％；治愈率90％。
对照组：150例带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮患者治疗效果附表如下：
对照组：
带状疱疹的患者13例：治愈者8例，显效者2例，有效者0例，无效者3例；
黄水疮的患者22例：治愈者15例，显效者1例，有效者2例，无效者4例；
冻疮的患者9例：治愈者6例，显效者1例，有效者0例，无效者2例；
褥疮的患者13例：治愈者7例，显效者2例，有效者2例，无效者2例；
例；
湿疹的患者14例：治愈者13例，显效者0例，有效者0例，无效者1例；
乳痈的患者20例：治愈者16例，显效者1例，有效者1例，无效者2例；
臁疮的患者10例：治愈者4例，显效者0例，有效者0例，无效者6例。
对照组：150例带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮患者治疗效果附表如下：
| 病例数 | 治愈数 | 显效数 | 有效数 | 无效数 | 有效率 | |
| 带状疱疹 | 13 | 8 | 2 | 0 | 3 | 76.92％ |
| 黄水疮 | 22 | 15 | 1 | 2 | 4 | 81.82％ |
| 冻疮 | 9 | 6 | 1 | 0 | 2 | 77.78％ |
| 褥疮 | 13 | 7 | 2 | 2 | 2 | 84.62％ |
| 烧烫伤 | 21 | 17 | 1 | 2 | 1 | 95.24％ |
| 皮肤瘙痒 | 28 | 25 | 2 | 1 | 0 | 100％ |
| 湿疹 | 14 | 13 | 0 | 0 | 1 | 92.86％ |
| 乳痈 | 20 | 16 | 1 | 1 | 2 | 90％ |
| 臁疮 | 10 | 4 | 0 | 0 | 6 | 40％ |
对照组：总有效率86％；治愈率为74％。
结论：从表中可以得出治疗组优于对照组，治疗组总有效率94％＞对照组总有效率86％；治疗组的治愈率90％＞对照组的74％。
典型病例：
患者王某某，男，68岁，就诊时间2015年6月13日初诊，河南省商丘市示范区张阁镇土楼村人，主诉：左下肢青紫溃烂十余年，10年前因农田工作时碰破左下肢，再不敛口愈合，在这期间曾去过商丘市第一人民医院、商丘市第三人民医院就诊，诊断为臁疮，治疗多次均不见好转，后来没办法就在当地诊所里不定期的换药冲洗。
院就诊，诊断为臁疮，治疗多次均不见好转，后来没办法就在当地诊所里不定期的换药冲洗。
诊断：臁疮，即是下肢溃疡，查体：血压130/80mmHg，心率85次/分，体温36.5摄氏度，视诊：左下肢青紫、溃烂、流水、溃烂面积为直径3cm圆形创面，青紫面为10*15cm，下肢肿胀。治疗：用双氧水冲洗创面后外涂抹本发明药膏，一日2次，坚持每天换药膏，一月为1个疗程，2个疗程后治愈。
患者万某，67岁，女，河南省商丘市虞城县古王集乡王集东村八组人，就诊时间：2017年7月8日，主诉：一周前左上肢及左侧胸前、后出现热痛症状，然后起水泡，在当地卫生室输液治疗三天后，商丘市第三人民医院确诊为带状疱疹，在门诊输液治疗三天，未见明显好转。
诊断：带状疱疹
既往史：无高血压、糖尿病、无药物过敏史。
查体：体温摄氏度36.9，血压130/85mmHg心率85次/分。
视诊：左上肢及左侧胸前、后有明显水疱结痂，未退现象，有明显新出皮疹及水疱。
治疗：用本发明药膏涂抹患处，一日3-5次，坚持每天换药膏，7天后痊愈(7天为1个疗程)。
患者张某某，女，25岁，河南省商丘市虞城县古王集乡老庄村人，2015年3月6日前来就诊：哺乳期妇女，左乳红肿、疼痛，有2.5*3cm大小硬块，局部发热，体温摄氏37.3，三天前在商丘市第三人医院诊断为乳痈，并口服清热类药物治疗，口服期间患者未见明显好转，听朋友介超到我处治疗。使用本发明药物治疗，让其一日2次涂抹患处，坚持每天换药膏，每天前换药，患者用药一天后疼痛减轻，三天后疼痛基本消失，五天后硬块消失(1月为1个疗程)，局部手感温度正常，体温摄氏36.4，指标正常，患者痊愈。
患者李某某，女，6岁，河南省虞城县古王集乡大李楼村人，就诊时间：2017年3月25日，主诉：头部三日前出现痒，然后耳朵周围及四肢出现痒，出现红色的疹子，随后破溃，流水及脓性物体。
视诊：头部、面部、前胸、四肢有红疹，有疹子破溃后，流出黄色液体，粘稠，部分已化脓。
诊断：黄水疮
治疗；使用本发明药物治疗，使用方法：温水清洗患处后，一日2次涂抹药膏，坚持每天换药膏，医嘱：忌食辛辣食物，建议复诊。据患者自述：用药当天就止住痒了，几天后破溃的皮肤就没有粘性液体流出，第七天部分开始结痂。
第二诊：头部有部分结痂皮疹，面部、四肢、胸部结痂已经脱落，未出现新皮疹，患者痊愈，无需用药，嘱咐患者平常勤洗澡，多饮水。(7天为1个疗程)
患者张某某，男，13岁，河南省商丘市虞城县古王集一中学生，就诊时间：2017年12月20日，主诉：耳朵、面部疼痛一周左右，有硬块，面部有破溃，双手溃烂一周之久，晚上疼痛难忍，平常骑自行车上学。
视诊：耳朵、面部皮肤有结痂，部分破溃，双手红肿，破溃皮肤化脓。
诊断：冻疮
治疗：使用本发明药膏治疗，温热水清洗患处，然后每处取1-2g药膏涂于患处，一日二次，每天坚持换药，医嘱：忌食辛辣实物，出门保暖，建议一周后复诊。
第二诊：据患者自述：涂抹上药膏当天冻伤部位发痒减轻，第二天红肿部位
治疗：患者康复，无需用药。
医嘱：平时注意保暖、防冻。(7天为1个疗程)
患者孔某某，男，8岁，河南省商丘市虞城县古王集乡孔楼村人，就诊时间：2017年6月23日，主诉：半小时前被火锅汤烫伤，疼痛难忍。视诊：左胸前、双上肢、双手红肿，有水疱、有溃烂、皮肤缺失。体格检查：体温摄氏37.8，心率90次/分，血压：110/70mmHg。诊断：烫伤，治疗：使用本发明药膏涂抹，使用方法：每次取1-2g药膏抹于患处，一日2次，每天坚持换药，医嘱：休息，多饮水。第二诊：四天后疼痛明显减轻，体温回复正常，红肿现象明显减轻。视诊：左胸部，双上肢、双手无红肿、无水疱、有溃烂皮肤，溃烂面积明显缩小。嘱咐患者继续治疗，3个疗程后治愈。(7天为1疗程)
患者张某某，男，7岁，河南省商丘市虞城县古王集乡王集东村人，就诊时间：2018年4月12日，主诉：一月前开始全身起红疙瘩，水疱样皮疹，瘙痒难忍，20天前曾去商丘市第一人民医院就诊：诊断为皮肤瘙痒症，取药治疗后未见明显好转。视诊：左上、下肢，右上下肢，前胸、后背均有散在的红色丘疹，皮肤部分破溃。诊断：皮肤瘙痒症，治疗：使用本发明药物治疗，每次涂抹药膏于患处，一日两次，坚持每天换药。第二诊：3天后皮肤瘙痒明显减轻，皮疹减少，嘱咐患者继续按原方法治疗，10天后患者康复。(7天为1个疗程)
患者王孙氏，女，70岁，河南省商丘市古王集乡吴庄村人，就诊时间：2016年8月22日，主诉：患者一月前后背、臀部、后脚跟皮肤开始溃烂，化脓，经商丘市第一人民医院、商丘市第三人民医院等多家医院诊治，均未能痊愈。既往史：有高血压史、脑血栓后遗症，长期卧床不能自理。视诊：后背有两块5*7cm大小的化脓溃疡面，两臀部有4*5cm化脓溃疡面，右脚跟处有3*2cm大小化脓溃疡面。
大小的化脓溃疡面，两臀部有4*5cm化脓溃疡面，右脚跟处有3*2cm大小化脓溃疡面。
诊断：使用本发明药膏治疗，用温开水清洗溃疡面后，涂抹上药膏即可，一日两次换药，每天坚持按时换药。医嘱：要有专人护理，勤给病人翻身，保持溃疡面不要长时间挤压。
第二诊：2016年9月10日就诊：据患者自述：用药三天后就发现再无化脓性物体，一周后发现溃疡面积明显变小。视诊：后背有两块3*3cm大小溃疡面、两臀部有2*1cm大小溃疡面、右脚跟处有1*1cm化脓性溃疡面，溃疡处均未见化脓组织，均有新生肉芽长出。嘱咐患者继续按原方治疗，第三诊：2016年9月20日就诊；除后背溃疡面，其余处全部愈合，后背处有两块1*0.5cm大小溃疡面，效不改方，继续治疗，又治疗5天后，溃疡面全部愈合。
Claims (4)
1.一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于由以下重量份配比的原料制成：(用量为重量份)
2.按照权利要求1所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于由以下配比的原料制成：(用量为重量份)
3.按照权利要求1或2所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于：它有下列步骤制成：
第一步选用药物、炮制药物：
(1)密陀僧：为粗制氧化铅，以往取自方铅矿提炼银、铅时沉积于炉底的副产品，目前系将铅熔融后，用长棍取出浸入冷水中，熔铅冷却后变成氧化铅固体，即为密陀僧；
(2)雄黄：为硫化物类矿物雄黄的矿石，雄黄在矿中质软如泥，见空气即变坚硬，一般用竹刀剔取其熟透部分，除去杂质泥土；
(3)当归：为伞形科植物当归的根，拣去杂质，洗净，切片晒干；
(4)木鳖子：为葫芦科植物木鳖子的成熟种子，除去杂质，洗净，晒干，用时连壳打碎，或去壳取仁；
(5)大黄：为蓼科植物掌叶大黄、唐古特大黄或药用大黄的根茎，9-10月间选择生长3年以上的植株，挖取根茎，切除茎叶、支根，刮去粗皮及顶牙，风干、烘干或切片晒干；
(6)黄芩：为唇形科植物黄芩的根，拣去杂质，除去残茎，用凉水浸润或置开水中稍浸捞出，润透后切片晒干；
(7)黄连：为毛莨科植物黄连、三角叶黄连、峨嵋野连或云南黄连的根茎，拣去杂质，洗净泥土，润透，切片，阴干；
(8)血竭：为棕榈科植物麒麟竭果实及树干中的树脂，拭去灰尘，敲成小块，于冬季干燥天气，放在石灰坛内使燥，然后乘脆研末；
(9)芙蓉叶：为锦葵科植物木芙蓉的叶，夏秋季采摘叶，阴干或晒干，取原药材，除去杂质，喷淋清水，稍润，切丝，干燥；
(10)乳香：为橄榄科植物卡氏乳香树的胶树脂，捡去砂子杂质；
(11)没药：为橄榄科植物没药或爱伦堡没药的胶树脂；
(12)苦参：为豆科植物苦参的根，捡尽杂质，除去残径，洗净泥土，用水浸泡，捞出，润透，切片，晒干；
(13)荆芥：为唇形科植物荆芥的全草，捡尽杂质，用水略泡，捞出切断，晒干；
(14)虫白蜡：为介壳虫科昆虫白蜡虫的雄虫，8-9月间采腊，清晨用刀将包有腊质的树枝切下，放入沸水锅中煮之，使腊质熔化而浮于水面，冷后凝结成块，取出，再加水加热熔化，过滤后凝固即成；
(15)野猪脂：为猪科动物野猪的脂肪；
第二步：先将血竭、薄荷脑研碎，备用；首先熬制野猪脂，微火加热熔化，继续加热至摄氏85-90度时，依次下密陀僧、雄黄、当归、木鳖子、大黄、黄芩、黄连、芙蓉叶、苦参、荆芥、乳香、没药，煎炸以上诸药，用油煎至黑枯色；次下虫白蜡、凡士林，继续煎炸5分钟后，将药渣滤净，最后下黄丹、单硬脂酸甘油酯，用柳枝搅拌，变为黑色，然后将血竭、薄荷脑粉掺入膏中，拌匀，软硬适宜，瓷盒内贮藏。
4.按照权利要求1或2或3所述的一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂，其特征在于：治疗带状疱疹、黄水疮、冻疮、褥疮、烧烫伤、皮肤瘙痒、湿疹、乳痈、臁疮等。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811083504.9A CN108926651A (zh) | 2018-09-18 | 2018-09-18 | 一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811083504.9A CN108926651A (zh) | 2018-09-18 | 2018-09-18 | 一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108926651A true CN108926651A (zh) | 2018-12-04 |
Family
ID=64443397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811083504.9A Withdrawn CN108926651A (zh) | 2018-09-18 | 2018-09-18 | 一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108926651A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109549916A (zh) * | 2019-01-16 | 2019-04-02 | 史德良 | 一种改善和治疗湿疹、过敏、口水疹、尿布疹、间擦疹的护肤品组合物及其应用 |
| CN111265583A (zh) * | 2020-03-20 | 2020-06-12 | 王殿国 | 一种治疗皮肤疮、疖、痈、脓肿、肿痛的中药组合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105194044A (zh) * | 2015-10-19 | 2015-12-30 | 树钢 | 用于治疗皮肤病的中药组合物及其制备方法 |
-
2018
- 2018-09-18 CN CN201811083504.9A patent/CN108926651A/zh not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105194044A (zh) * | 2015-10-19 | 2015-12-30 | 树钢 | 用于治疗皮肤病的中药组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 任超西等: "三黄生肌膏外敷治疗褥疮128 例", 《中医外治杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109549916A (zh) * | 2019-01-16 | 2019-04-02 | 史德良 | 一种改善和治疗湿疹、过敏、口水疹、尿布疹、间擦疹的护肤品组合物及其应用 |
| CN111265583A (zh) * | 2020-03-20 | 2020-06-12 | 王殿国 | 一种治疗皮肤疮、疖、痈、脓肿、肿痛的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
| CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
| CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
| CN102048894A (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN103768567B (zh) | 一种黑膏药及其制备方法 | |
| CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
| CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
| CN108926651A (zh) | 一种治疗痈疖疔疮、脓肿、带状疱疹、皮肤瘙痒的中药膏剂 | |
| CN103239662A (zh) | 兽用驱虫中药制剂 | |
| CN108042770A (zh) | 治疗肾炎的中药熏洗剂、其制备方法和使用方法 | |
| CN108042750A (zh) | 小儿益智灵 | |
| CN103860787B (zh) | 含有花蛤有效成分的治疗痤疮的外用中药 | |
| CN105148065A (zh) | 用于治疗烫伤的中药散及制备方法 | |
| CN104666799A (zh) | 软组织损伤活血化瘀药酒及制备方法 | |
| CN101342331A (zh) | 治疗肺炎和上呼吸道感染的中药喷剂 | |
| CN104435865B (zh) | 一种治疗心律不齐的中药制剂及制备方法 | |
| CN103721028B (zh) | 一种治疗心绞痛的药物及制备方法 | |
| CN103877356B (zh) | 一种治疗心肌梗死的中药制剂及制备方法 | |
| CN106943574A (zh) | 一种治疗精神分裂症的药物及其制备方法 | |
| CN108785382A (zh) | 一种用于治疗湿疹的中药 | |
| CN106620408A (zh) | 一种治疗恶性葡萄胎的药物及其制备方法 | |
| CN101244174B (zh) | 一种治疗脉管炎的药物及其制备方法 | |
| CN105832965A (zh) | 治疗烧烫伤的中药制剂及其制备方法 | |
| CN105560582A (zh) | 治疗冻疮的消肿止痒药膏及制法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181204 |